[
  {
    "ts": null,
    "headline": "Pfizer (PFE) Advances But Underperforms Market: Key Facts",
    "summary": "Pfizer (PFE) closed the most recent trading day at $21.91, moving +1.48% from the previous trading session.",
    "url": "https://finnhub.io/api/news?id=f5e918586aaf8879da1966d443a5d0f69b5af20797e212224b7313225a3547c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744407916,
      "headline": "Pfizer (PFE) Advances But Underperforms Market: Key Facts",
      "id": 133896006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) closed the most recent trading day at $21.91, moving +1.48% from the previous trading session.",
      "url": "https://finnhub.io/api/news?id=f5e918586aaf8879da1966d443a5d0f69b5af20797e212224b7313225a3547c0"
    }
  },
  {
    "ts": null,
    "headline": "Is Pfizer Inc. (PFE) A Cheap NYSE Stock to Invest in According to Hedge Funds?",
    "summary": "We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends in […]",
    "url": "https://finnhub.io/api/news?id=f525a73015d4cc526d266667d7f10db96d97a7247d7cfcc7bf206ad5bc9d17d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744403707,
      "headline": "Is Pfizer Inc. (PFE) A Cheap NYSE Stock to Invest in According to Hedge Funds?",
      "id": 133896007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends in […]",
      "url": "https://finnhub.io/api/news?id=f525a73015d4cc526d266667d7f10db96d97a7247d7cfcc7bf206ad5bc9d17d4"
    }
  },
  {
    "ts": null,
    "headline": "Novavax slides after RFK Jr. casts doubts about COVID vaccine",
    "summary": "Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay. The Secretary of Health and Human Services pointed to the vaccine’s single-antigen composition as the reason for the push back, adding that the FDA is “shifting our priorities to multiple-antigen vaccines.” SHIFTING PRIORITIES: The Food and Drug Administration is sitting on the decision to grant full approval for Novavax COVID-19 shot. In an interview wit",
    "url": "https://finnhub.io/api/news?id=9b6d2893f2c9dde9ea83a37f9f799ebc6249324346fe177915277c3aa29ae0f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744384814,
      "headline": "Novavax slides after RFK Jr. casts doubts about COVID vaccine",
      "id": 133880835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay. The Secretary of Health and Human Services pointed to the vaccine’s single-antigen composition as the reason for the push back, adding that the FDA is “shifting our priorities to multiple-antigen vaccines.” SHIFTING PRIORITIES: The Food and Drug Administration is sitting on the decision to grant full approval for Novavax COVID-19 shot. In an interview wit",
      "url": "https://finnhub.io/api/news?id=9b6d2893f2c9dde9ea83a37f9f799ebc6249324346fe177915277c3aa29ae0f0"
    }
  },
  {
    "ts": null,
    "headline": "Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential",
    "summary": "Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential",
    "url": "https://finnhub.io/api/news?id=0b5d6f555d02b8f7d0b1182c47aedfaf38d42c1bde5dc51c437840ff1102cda6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744377654,
      "headline": "Puma Biotechnology: Initiating Hold Rating With Limited Near-Term Upside And Uncertain Pipeline Potential",
      "id": 133879910,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=0b5d6f555d02b8f7d0b1182c47aedfaf38d42c1bde5dc51c437840ff1102cda6"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Tariffs Are Coming. Investors Underestimate the Risk.",
    "summary": "Pharma Tariffs Are Coming. Investors Underestimate the Risk.",
    "url": "https://finnhub.io/api/news?id=d7ed624044a165ef9e4f90ed98a5ca13b641b58b3a3ee802a806a6969c4982fc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744377180,
      "headline": "Pharma Tariffs Are Coming. Investors Underestimate the Risk.",
      "id": 134146899,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pharma Tariffs Are Coming. Investors Underestimate the Risk.",
      "url": "https://finnhub.io/api/news?id=d7ed624044a165ef9e4f90ed98a5ca13b641b58b3a3ee802a806a6969c4982fc"
    }
  },
  {
    "ts": null,
    "headline": "Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock",
    "summary": "Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=363a09b4f573a227b02ba4e0f13fc549ba9aac35738938b46a089d5df040ead3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744376414,
      "headline": "Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock",
      "id": 133880837,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=363a09b4f573a227b02ba4e0f13fc549ba9aac35738938b46a089d5df040ead3"
    }
  },
  {
    "ts": null,
    "headline": "Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer",
    "summary": "Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why NVAX maintains a \"Hold\" rating.",
    "url": "https://finnhub.io/api/news?id=33cde9f5159be311b9596bed99b110bf1d136b39fbec25a00518c5c34e92f54a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744360778,
      "headline": "Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer",
      "id": 133878610,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why NVAX maintains a \"Hold\" rating.",
      "url": "https://finnhub.io/api/news?id=33cde9f5159be311b9596bed99b110bf1d136b39fbec25a00518c5c34e92f54a"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Ads & Social Media – 2025 Annual Meeting",
    "summary": "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...",
    "url": "https://finnhub.io/api/news?id=b7151798c924089278f04c53f86035cdf1c080bce60165a6c1d84ce591a09d45",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744355167,
      "headline": "Pfizer : Ads & Social Media – 2025 Annual Meeting",
      "id": 133878078,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...",
      "url": "https://finnhub.io/api/news?id=b7151798c924089278f04c53f86035cdf1c080bce60165a6c1d84ce591a09d45"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer : Email to shareholders – 2025 Annual Meeting",
    "summary": "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...",
    "url": "https://finnhub.io/api/news?id=c88da2b3eb2bd39e46f75ddeced6583a22f7ae9b9630776b05e0f2da16a15034",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744355166,
      "headline": "Pfizer : Email to shareholders – 2025 Annual Meeting",
      "id": 133878079,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to...",
      "url": "https://finnhub.io/api/news?id=c88da2b3eb2bd39e46f75ddeced6583a22f7ae9b9630776b05e0f2da16a15034"
    }
  },
  {
    "ts": null,
    "headline": "6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility",
    "summary": "Though the stock market is still historically pricey, a few phenomenal bargains have cropped up.",
    "url": "https://finnhub.io/api/news?id=11f7e3d2e02fd014af0ff8a9db54453ab1dd5739ea0767f020d3bed00e090c70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744355160,
      "headline": "6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility",
      "id": 133880838,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Though the stock market is still historically pricey, a few phenomenal bargains have cropped up.",
      "url": "https://finnhub.io/api/news?id=11f7e3d2e02fd014af0ff8a9db54453ab1dd5739ea0767f020d3bed00e090c70"
    }
  }
]